Sanofi

Thermo Fisher Scientific (NYSE:TMO) announced that it completed its acquisition of a Sanofi facility in New Jersey. The company acquired Sanofi’s state-of-the-art sterile fill-finish and packaging site in Ridgefield, New Jersey. In July, the company announced its plans to acquire this site and continue producing a portfolio of Sanofi therapies there while opening the facility…

Thermo Fisher Scientific recently announced plans to acquire Sanofi’s sterile manufacturing site in Ridgefield, New Jersey, and continue producing a portfolio of Sanofi therapies there while opening the facility to additional pharmaceutical and biotech customers. The plant performs sterile fill-finish and packaging, and has more than 200 employees, all of whom will join Thermo Fisher…

Sanofi recently announced that it is investing €40 million in its Lyon Gerland bioproduction site as it seeks to bolster its position in the immunology space. The investment will support production in France of the transplant drug Thymoglubulin, including €25 million toward developing and manufacturing a second-generation version of the drug. The remaining €15 million…

Sanofi announced today that it’s shipping Beyfortus injection doses to the U.S. to ensure availability ahead of respiratory syncytial virus (RSV) season. The company shipped 50mg and 100mg injection doses of Beyfortus (nirsevimab-alip) to private healthcare providers and the Centers for Disease Control and Prevention for its Vaccines for Children program. Sanofi expects the U.S.…

Sanofi recently announced that it will spend €1.3 billion ($1.4 billion) over the next five years to build a new insulin production facility at its BioCampus in Frankfurt Höchst, Germany. The 36,000 m2 (equivalent to nearly 388,000 ft2) facility will replace existing insulin production plants. Paris-based Sanofi says several hundred highly qualified specialists will work…

Pharma giants Sanofi and Novartis came in at No. 7 and 17, respectively, in Time magazine’s “Most Sustainable Companies of 2024” rankings. Overall, nearly 40 of the 500 companies on the list fell under the category of Chemicals, Drugs & Biotechnology. Other large pharma companies making it into the top half of the 500 included…

French pharma giant Sanofi recently opened a pediatric and adult vaccine manufacturing facility on its Toronto campus. The facility officially opened on May 30. According to Sanofi, the new plant significantly increases its capacity to meet growing demand in Canada and around the world for pediatric and adult vaccines for pertussis (whooping cough), diphtheria and…

Genentech and Sanofi both plan to make significant headcount reductions in the  San Francisco area, according to notices filed in the state of California. The San Francisco Chronicle first reported the layoffs. The companies both filed WARN notices to notify the state of their intent to reduce their workforces. Genentech, a Roche unit, will permanently…

French pharma giant Sanofi launched a new global program aimed at providing financial, social and emotional assistance to employees diagnosed with cancer or other critical illnesses. Dubbed “Cancer & Work: Acting Together,” the program guarantees continued salary and benefits for up to one year for affected staff regardless of role or location. It also incorporates…

Reuters reports that a number of big-name drugmakers, including Pfizer, Sanofi and Takeda plan to raise drug prices to start the year. According to the report, the price hikes apply to more than 500 drugs. Excluding different doses and formulations, the reach extends to more than 140 brands of drugs. Reuters said healthcare research firm 3…